A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence
<ns5:p>Syntenin-1 is the Syndecan-binding protein 1 and a PDZ domain–containing adaptor protein that regulates diverse cellular processes through its interactions with transmembrane receptors, cytoskeletal components, and signaling molecules. Here we have characterized twelve Syntenin-1 commercial antibodies for western blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility issues by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While the use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.</ns5:p>
Authors
- Sara González Bolívar (ORCID: https://orcid.org/0000-0002-4299-8281)
- Carl Laflamme (ORCID: https://orcid.org/0000-0001-5906-025X)
- Peter S. McPherson (ORCID: https://orcid.org/0000-0001-7806-5662)
- Vincent Francis (ORCID: https://orcid.org/0009-0000-7535-8718)
- Vera Ruíz Moleón (ORCID: https://orcid.org/0000-0003-3728-3158)
- Charles Alende (ORCID: https://orcid.org/0009-0005-4611-6134)
- Maryam Fothouhi
- Riham Ayoubi
Institutions
- Montreal Neurological Institute and Hospital (CA)
Publication Details
- Journal
- F1000Research
- Published
- 2026-06-26
- DOI
- https://doi.org/10.12688/f1000research.183125.1
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Bayer
- Emory University
- Québec Consortium for Drug Discovery